Azenta (AZTA) closes B Medical Systems sale to Thelema S.à r.l.
The B Medical Systems divestiture is settled. Azenta, Inc. (Nasdaq: AZTA) confirmed the close of the unit's sale to Thelema S.à r.l. on July 8, 2026, with the transaction completing on July 1. Burlington, Mass.-based…
Key takeaways
- Azenta, Inc. (Nasdaq: AZTA) confirmed the close of its B Medical Systems sale to Thelema S.à r.l. on July 8, 2026.
- The transaction officially completed on July 1, 2026.
- Azenta first disclosed the deal on December 29, 2025, making the timeline from disclosure to close roughly six months.
- Thelema S.à r.l. was the named buyer throughout the process.
- No financial terms were included in the announcement.
The B Medical Systems divestiture is settled. Azenta, Inc. (Nasdaq: AZTA) confirmed the close of the unit's sale to Thelema S.à r.l. on July 8, 2026, with the transaction completing on July 1. Burlington, Mass.-based Azenta had first disclosed the deal on December 29, 2025.
A six-month timeline
The gap between disclosure and close runs roughly six months. Azenta made the B Medical Systems sale public on December 29, 2025. The deal cleared on July 1, 2026. Formal confirmation arrived a week later, on July 8. Thelema S.à r.l. is the named buyer throughout.
The setup from here
B Medical Systems has changed hands. The July 8 announcement described the transaction as "previously disclosed," consistent with the December 2025 filing. No financial terms appeared in the announcement excerpt. For AZTA holders, the next watch point is any management update on the remaining portfolio following the July 1 close date.
Related reading
Filed via prnewswire.com